Treatment analysis of 26 patients with breast ductal carcinoma in situ.
- Author:
Lan-bo ZHANG
1
;
Yu-xiu XU
;
Jian-li GENG
;
Yu-hai ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Breast Neoplasms; mortality; pathology; surgery; Carcinoma in Situ; mortality; pathology; surgery; Carcinoma, Ductal, Breast; mortality; pathology; surgery; Female; Humans; Lymph Node Excision; Mastectomy; Middle Aged; Retrospective Studies
- From: Chinese Journal of Oncology 2003;25(2):195-197
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the appropriate surgical treatment for breast ductal carcinoma in situ (DCIS).
METHODSTwenty-six such patients treated between 1992 and 2001 were retrospectively analyzed. Among them, 3 patients were treated by simple mastectomy, 23 patients by mastectomy and axillary lymph node dissection, 8 patients by chemotherapy and one patient by radiotherapy after operation. Median follow-up was 42 m (rang 12 - 112 m).
RESULTSExcept 3 of these 26 patients lost in follow-up and 1 patient died from diabetes mellitus, all the other 22 patients survived over 5 years. All lymph nodes dissected from 23 patients were negative. After surgery, 3 patients developed lymph edema of the arm.
CONCLUSIONDCIS, lacking the potential of metastasis, is not invasive. Conservative breast surgery without lymph node dissection is feasible for most DCIS patients.
